Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jeffrey L. Duerk, Avon Lake US

Jeffrey L. Duerk, Avon Lake, OH US

Patent application numberDescriptionPublished
20080218169METHODS FOR FAT SIGNAL SUPPRESSION IN MAGNETIC RESONANCE IMAGING - The present invention is directed to methods for chemical species signal suppression in magnetic resonance imaging procedures, wherein Dixon techniques are enhanced by continuously sampling techniques. In the invention, k-space data is acquired during the entire period of read gradient associated with a gradient echo pulse acquisition scheme. The invention utilizes a total sampling time (TST) acquisition during the entire read gradient, using three echoes of a TST data set to achieve chemical species separation in both homogenous fields as well as areas of field inhomogeneity. As an example, a continuously sampled rectilinearly FLASH pulse sequence is modified such that the time between echoes was configured to be 2.2 milliseconds, with TE selected to allow 180° phase variation in the fat magnetization between each of the three TE's (TE09-11-2008
20080221428Chemical Shift Markers for Improved Wireless Fiducial Marker Tracking - A new and improved method for tracking and/or spatial localization of an invasive device in Magnetic Resonance Imaging (MRI) is provided. The invention includes providing an invasive device including a marker having a chemically shifted signal source with a resonant frequency different from the chemical species of the subject to be imaged, applying a pulse sequence, detecting the resulting RF magnetic resonance signals, and determining the 3D coordinates of the marker. The invention also includes generating scan planes and reconstructing an image from the detected signals to generate an image having the marker contrasted from the subject. The invasive device includes a marker having a chemically shifted signal source which has a resonant frequency different from the chemical species of the subject to be imaged for use in tracking the device during imaging.09-11-2008
20080278162Cartesian continuous sampling with unequal gradients - Example methods and apparatus control ratios between a maximum gradient amplitude (MGA) of a readout lobe (G11-13-2008
20090177075Resolution enhanced T1-insensitive steady state imaging (RE-TOSSI) - Systems, methods, and other embodiments associated with RE-TOSSI are described. One system embodiment includes an MRI apparatus configured to produce a RE-TOSSI pulse sequence and to acquire T2-weighted images in response to the RE-TOSSI pulse sequence. An example RE-TOSSI pulse sequence includes a TOSSI portion and a non-inverting, non-TOSSI portion.07-09-2009
20090261825DARK BLOOD BALANCED STEADY STATE FREE PRECESSION IMAGING - Systems, methods, and other embodiments associated with controlling a magnetic resonance imaging (MRI) apparatus to perform a balanced steady state free precession (bSSFP) technique that includes magnetization preparation with differentiated velocity encoding and spoiling residual transverse magnetization are described. The example systems, methods, and other embodiments are also associated with acquiring a dark blood image in response to the bSSFP technique. A dark blood image is one in which NMR signal acquired from an object subjected to the bSSFP technique and magnetization preparation includes NMR signal from flowing spins and NMR signal from non-flowing spins in a desired ratio.10-22-2009
20090261827MITIGATING SATURATION ARTIFACTS ASSOCIATED WITH INTERSECTING PLANE TRUEFISP ACQUISITIONS THROUGH GROUPED REVERSE CENTRIC PHASE ENCODING - Systems methods, and other embodiments associated with acquiring intersecting TrueFISP images using grouped reverse centric phase encoding are described. One example method includes controlling an MRI apparatus to produce a TrueFISP sequence that delays acquisition of the center of k-space to reduce saturation banding artifacts. The example method also includes controlling the MRI apparatus to produce a TrueFISP sequence that reduces eddy current artifacts by grouping (e.g., pairing) lines in k-space. The method concludes by acquiring NMR signal in response to the TrueFISP sequence.10-22-2009
20090264730MAGNETIC RESONANCE IMAGING (MRI) GUIDED ABLATION - Systems, methods, and other embodiments associated with tracking an ablative device and monitoring an ablation produced by the ablative device are described. One example method includes acquiring a magnetic resonance (MR) image of an ablative device inserted in a body and selectively controlling positioning of the ablative device based, at least in part on the MR image. The MR image may be continuously provided in real-time by an interventional MR imaging apparatus programmed to image using a tri-orthogonal plane sequence. The method may also include acquiring an MR image of an ablation performed by the ablative device, and selectively controlling the ablative device based, at least in part, on the MR image. The MR image may also be provided by the IMRI apparatus operating according to a tri-orthogonal plane sequence. In one example, the ablation may treat hypopharyngeal obstructive sleep apnea by reducing tongue base volume.10-22-2009
20100063380Steady state dark blood magnetic resonance imaging - Systems, methods, and other embodiments associated with steady state dark blood magnetic resonance imaging MRI are described. One example method includes controlling an MRI apparatus to produce a steady state pulse sequence. The example method may also include controlling the MRI apparatus to generate radio frequency (RF) energy and magnetic gradients associated with the steady state pulse sequence. The steady state pulse sequence is different from conventional steady state pulses in that it is characterized by regularly spaced slice selection excitation pulses to excite a region to be imaged in an object to be imaged using a consistent repetition time (TR), a set of readout modules, and a set of a magnetization preparation modules. A magnetization preparation module is characterized by gradients associated with imaging not being active, gradients associated with slice selection being active, and RF pulses associated with slice selection being active.03-11-2010
20100066365METHODS FOR FAT SIGNAL SUPPRESSION IN MAGNETIC RESONANCE IMAGING - The present invention is directed to methods for chemical species signal suppression in magnetic resonance imaging procedures, wherein Dixon techniques are enhanced by continuously sampling techniques. In the invention, k-space data is acquired during the entire period of read gradient associated with a gradient echo pulse acquisition scheme. The invention utilizes a total sampling time (TST) acquisition during the entire read gradient, using three echoes of a TST data set to achieve chemical species separation in both homogenous fields as well as areas of field inhomogeneity. As an example, a continuously sampled rectilinearly FLASH pulse sequence is modified such that the time between echoes was configured to be 2.2 milliseconds, with TE selected to allow 180° phase variation in the fat magnetization between each of the three TE's (TE03-18-2010
20100076301ADAPTIVE IMAGING PARAMETERS WITH MRI - Systems, methodologies, media, and other embodiments associated with automatically adapting MRI controlling parameters are described. One exemplary method embodiment includes configuring an MRI apparatus to acquire MR signal data using a non-rectilinear trajectory. The example method may also include acquiring MR signals, transforming the MR signals into image data, and selectively adapting the MRI controlling parameters based, at least in part, on information associated with the MR signals.03-25-2010
20100106007DOUBLE-CONTRAST TECHNIQUE FOR MRI-GUIDED VASCULAR INTERVENTIONS - Methods for confirming location of a catheter tip relative to a targeted location in a blood vessel of a subject and improving visualization of the blood vessels downstream of the catheter tip are provided. The methods comprise acquiring and displaying a first modified MR image of the subject's blood vessels between an insertion site for the catheter and the targeted location; acquiring and displaying a sequence of modified MR images of the blood vessels to monitor advancement of an inserted catheter from the insertion site to an intraluminal stop site at or near the targeted location; delivering a bolus of a magnetic resonance contrast agent through the tip of the catheter and to the intraluminal stop site, wherein the magnetic contrast agent alters the first modified MR image of the subject's blood vessels; acquiring and displaying an updated second MR modified image of the blood vessels at and downstream of the tip of the catheter. Systems and computer readable medium storing computer executable instructions operable to perform computer executable aspects of the present methods are also provided.04-29-2010
20100322865DEUTERATED METABOLIC WATER PRECURSOR FOR DETECTING AND TREATING DISEASED TISSUE - A method of diagnosing a mitochondrial related disease in a subject includes administering a deuterated metabolic water precursor to the subject, measuring a rate of deuterated water formation in a sample region of the subject, and comparing the measured deuterated water formation in the sample region to a control value. A difference between the rate of deuterated water formation in the sample region compared to a control value is indicative of a mitochondrial related disease.12-23-2010
20110158477REDUCING EFFECTS OF ROTATIONAL MOTION - A method and system for improving image quality by correcting errors introduced by rotational motion of an object being imaged is provided. The object is associated with a fiducial mark. The method provides a computer executable methodology for detecting a rotation and selectively reordering, deleting and/or reacquiring projection data.06-30-2011

Patent applications by Jeffrey L. Duerk, Avon Lake, OH US